Skip to main content

Table 1 Baseline characteristics

From: A comparison of intraoperative goal-directed intravenous administration of crystalloid versus colloid solutions on the postoperative maximum N-terminal pro brain natriuretic peptide in patients undergoing moderate- to high-risk noncardiac surgery

 

Colloid

(n = 27)

Crystalloid

(n = 29)

Morphometrics

 Age, yrs

65

[range 53, 69]

61

[range 53, 68]

 BMI, kg−2

25

(3)

24

(3)

 Sex

  Men, No (%)

16

(59)

16

(55)

  Women, No (%)

11

(41)

13

(45)

ASA

 I, No. (%)

3

(11)

2

(7)

 II, No. (%)

15

(56)

17

(59)

 III, No. (%)

9

(33)

10

(34)

RCRI

 1 Point, (%)

24

(89)

26

(90)

 2 Point, (%)

3

(11)

3

(10)

Comorbidities

 Pulmonary Disease, No. (%)

4

(15)

4

(14)

 Hypertension, No. (%)

11

(41)

13

(45)

 Neurological Disease, No. (%)

2

(7)

3

(10)

 Diabetes, No. (%)

3

(11)

1

(3)

Long-Term Medication

 Beta Blocker, No. (%)

7

(26)

6

(21)

 ACE Inhibitor/AT1-Blocker, No. (%)

8

(30)

7

(24)

 Calcium antagonist, No. (%)

3

(11)

1

(3)

 Alpha Blocker, No. (%)

1

(4)

1

(3)

 Oral Antidiabetic, No. (%)

1

(4)

1

(3)

 Insulin use, No. (%)

1

(4)

0

(0)

Type of Surgery

 Pancreatic Surgery, No. (%)

4

(15)

9

(31)

 Hepatic Surgery, No. (%)

13

(48)

10

(34)

 Colorectal Surgery, No. (%)

9

(33)

9

(31)

 Other, No. (%)

1

(4)

1

(3)

Preoperative Laboratory Values

 Creatinine, mg/dL

0.8

[0.65, 0.92]

0.72

[0.63, 0.84]

 Haemoglobin, g/dL

13.2

[11.9, 14.0]

13.3

[11.6, 14.3]

 Haematocrit, %

38.1

± 3.5

38.8

± 3.4

 aPPT, sec

33.5

± 2.9

32.9

± 3.7

  1. Summary characteristics are presented as counts, percentages of patients and means ± SD, respectively. ASA American Society of Anaesthesiologists physical status, RCRI Revised Cardiac Risk Index, ACE Acetyl-Converting-Enzyme, AT1 Angiotensin, BMI Body-Mass-Index, aPTT Activated Partial Thromboplastin Time